% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{vanVeluw:269784,
author = {van Veluw, Susanne J and Benveniste, Helene and Bakker,
Erik N T P and Carare, Roxana O and Greenberg, Steven M and
Iliff, Jeffrey J and Lorthois, Sylvie and Van Nostrand,
William E and Petzold, Gabor C and Shih, Andy Y and van
Osch, Matthias J P},
title = {{I}s {CAA} a perivascular brain clearance disease? {A}
discussion of the evidence to date and outlook for future
studies.},
journal = {Cellular and molecular life sciences},
volume = {81},
number = {1},
issn = {1420-682X},
address = {Cham (ZG)},
publisher = {Springer International Publishing AG},
reportid = {DZNE-2024-00619},
pages = {239},
year = {2024},
abstract = {The brain's network of perivascular channels for clearance
of excess fluids and waste plays a critical role in the
pathogenesis of several neurodegenerative diseases including
cerebral amyloid angiopathy (CAA). CAA is the main cause of
hemorrhagic stroke in the elderly, the most common vascular
comorbidity in Alzheimer's disease and also implicated in
adverse events related to anti-amyloid immunotherapy.
Remarkably, the mechanisms governing perivascular clearance
of soluble amyloid β-a key culprit in CAA-from the brain to
draining lymphatics and systemic circulation remains poorly
understood. This knowledge gap is critically important to
bridge for understanding the pathophysiology of CAA and
accelerate development of targeted therapeutics. The authors
of this review recently converged their diverse expertise in
the field of perivascular physiology to specifically address
this problem within the framework of a Leducq Foundation
Transatlantic Network of Excellence on Brain Clearance. This
review discusses the overarching goal of the consortium and
explores the evidence supporting or refuting the role of
impaired perivascular clearance in the pathophysiology of
CAA with a focus on translating observations from rodents to
humans. We also discuss the anatomical features of
perivascular channels as well as the biophysical
characteristics of fluid and solute transport.},
subtyp = {Review Article},
keywords = {Humans / Brain: metabolism / Brain: pathology / Cerebral
Amyloid Angiopathy: metabolism / Cerebral Amyloid
Angiopathy: pathology / Animals / Amyloid beta-Peptides:
metabolism / Glymphatic System: metabolism / Glymphatic
System: pathology / Alzheimer Disease: metabolism /
Alzheimer Disease: pathology / Brain clearance (Other) /
Cerebral amyloid angiopathy (Other) / Cerebrospinal fluid
(Other) / Glymphatics (Other) / IPAD (Other) / Perivascular
spaces (Other) / Amyloid beta-Peptides (NLM Chemicals)},
cin = {AG Petzold ; AG Petzold},
ddc = {610},
cid = {I:(DE-2719)1013020},
pnm = {353 - Clinical and Health Care Research (POF4-353)},
pid = {G:(DE-HGF)POF4-353},
typ = {PUB:(DE-HGF)16},
pmc = {pmc:PMC11130115},
pubmed = {pmid:38801464},
doi = {10.1007/s00018-024-05277-1},
url = {https://pub.dzne.de/record/269784},
}